Myriad Genetics Expands Board of Directors with New Member and Announces Upcoming Retirement of Walter (Wally) Gilbert, Ph.D.

NEXT STORY
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
PREV STORY
Generation Bio Appoints Matthew Norkunas, M.D., MBA as Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Myriad Genetics Expands Board of Directors with New Member and Announces Upcoming Retirement of Walter (Wally) Gilbert, Ph.D.

NEXT STORY
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
PREV STORY
Generation Bio Appoints Matthew Norkunas, M.D., MBA as Chief Financial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

$245 Billion Active Pharmaceutical Ingredient (Innovative, Generic) Market – Global Forecast to 2024

Dublin, Jan. 15, 2019 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredient/ API Market by ...

author_avatar
NASDAQ Market News

Blueberries Medical Provides Corporate Update

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces that FDA Accepts ELZONRIS™ Biologics License Application (BLA) and Grants Priority Review

Conference call on BLA acceptance and commercial readiness scheduled for Monday, August 13, 2018 ...

author_avatar
NASDAQ Market News